Inactive Instrument

T. Rowe Price Group Stock price Nasdaq

Equities

Investment Management & Fund Operators

Sales 2024 * 6.82B Sales 2025 * 7.01B Capitalization 27.27B
Net income 2024 * 1.75B Net income 2025 * 1.81B EV / Sales 2024 * 3.64 x
Net cash position 2024 * 2.44B Net cash position 2025 * 1.78B EV / Sales 2025 * 3.64 x
P/E ratio 2024 *
15.5 x
P/E ratio 2025 *
14.9 x
Employees -
Yield 2024 *
4.04%
Yield 2025 *
4.13%
Free-Float 97.95%
More Fundamentals * Assessed data
Dynamic Chart
Bristol-Myers Squibb Company completed the acquisition of Karuna Therapeutics, Inc. from Capital International Investors, FMR LLC, The Vanguard Group, Inc., T. Rowe Price Group, Inc. and others. CI
T. Rowe Price Group's Assets Under Management Rise in February MT
T Rowe Price Group Insider Sold Shares Worth $1,034,147, According to a Recent SEC Filing MT
Sionna Therapeutics, Inc. announced that it has received $182 million in funding from a group of investors CI
T. Rowe Price Launches New and Innovative Retirement Income Tool to Help Optimize Social Security Benefits CI
EMEA Morning Briefing : Stock Futures Lower as China Sets Ambitious Growth Target DJ
INSTANT VIEW-Japan's Nikkei hits record high RE
T. Rowe Price Group Chairman Stromberg to Retire MT
T. Rowe Price Non-Executive Board Chair William Stromberg Retiring in May MT
T. Rowe Price Group, Inc. Announces Board Changes CI
Lambda, Inc. announced that it has received $320 million in funding from a group of investors CI
Freenome Holdings, Inc. announced that it has received $254 million in funding from a group of investors CI
ProfoundBio Co., Ltd. announced that it has received $112 million in funding from a group of investors CI
T. Rowe Price Group's Assets Under Management Rise in January From Previous Month MT
Lilac Solutions, Inc. announced that it has received $145 million in funding from a group of investors CI
More news
Managers TitleAgeSince
Chief Executive Officer 52 96-12-31
Director of Finance/CFO 51 05-12-31
Chairman 64 15-12-31
Members of the board TitleAgeSince
Director/Board Member 62 21-12-29
Director/Board Member 73 13-01-02
Director/Board Member 68 16-10-25
More insiders
T. Rowe Price Group, Inc. is an investment management company that provides investment advisory services to individual and institutional investors, retirement plans, and financial intermediaries. The group manages a broad range of American and international stock, blended asset, bond, and money market mutual funds and other investment portfolios. T. Rowe Price Group also provides investment advisory clients with related administrative services, including mutual fund transfer agent, accounting and shareholder services, participant recordkeeping and transfer agent services for defined contribution retirement plans, discount brokerage, and trust services. At the end of 2023, the group had USD 1,444.5 billion in assets under management.
Related indices
More about the company
  1. Stock
  2. Equities
  3. Stock T. Rowe Price Group Inc.
  4. Stock T. Rowe Price Group - Nasdaq